Publication:
Prognostic Value of Total Bilirubin in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention

Simple item page
dc.contributor.authorGul, Mehmet
dc.contributor.authorUyarel, Huseyin
dc.contributor.authorErgelen, Mehmet
dc.contributor.authorAkgul, Ozgul
dc.contributor.authorKaraca, Gurkan
dc.contributor.authorTuren, Selahattin
dc.contributor.authorUgur, Murat
dc.contributor.authorErturk, Mehmet
dc.contributor.authorKul, Seref
dc.contributor.authorSurgit, Ozgur
dc.contributor.authorBozbay, Mehmet
dc.contributor.authorUslu, Nevzat
dc.date.accessioned2020-10-22T20:21:41Z
dc.date.available2020-10-22T20:21:41Z
dc.date.issued2013-10-01T00:00:00Z
dc.description.abstractPrevious studies have shown that the serum total bilirubin (TB) concentration was inversely related with stable coronary artery disease, diabetes mellitus, hypertension, and metabolic syndromes. The relation between TB levels and in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction (STEM!) who undergo primary percutaneous coronary intervention (PCI) is not known. Data from 1,624 consecutive patients with STEMI who underwent primary PCI were evaluated. TB was measured after primary PCI, and the study population was divided into tertiles. The high TB group (n = 450) was defined as a value in the upper third tertile (>0.9 mg/dl) and the low TB group (n = 1,174) as any value in the lower 2 tertiles (0.90 mg/dl was identified as an effective cutpoint in patients with STEMI for in-hospital cardiovascular mortality (area under the curve 0.66, 95% confidence interval 0.55 to 0.76, p = 0.001). The mean follow-up period was 26.2 months. No differences were seen in the long-term mortality rates between the 2 groups. In conclusion, high TB is independently associated with in-hospital adverse outcomes in patients with STEMI who undergo primary PCI. However, no association was found with long-term mortality. (C) 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;111:166-171)
dc.identifier.citationGul M., Uyarel H., Ergelen M., Akgul O., Karaca G., Turen S., Ugur M., Erturk M., Kul S., Surgit O., et al., -Prognostic Value of Total Bilirubin in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention-, 29th Turkish Cardiology Congress of the Turkish-Society-of-Cardiology (TSC) with International Participation, Antalya, Türkiye, 26 - 29 Ekim 2013, cilt.62
dc.identifier.doi10.1016/j.jacc.2013.08.070
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24707
dc.identifier.wosWOS:000329858400052
dc.subjectMyocardial Infarction
dc.titlePrognostic Value of Total Bilirubin in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.idde3b14f6-9a18-4314-9407-d8b9ff2a5c4d
local.publication.isinternational1
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Prognostic Value of Total Bilirubin.pdf
Size:
305.58 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler